Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al
Plaintiff: Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant: Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc.
Case Number: 1:2022cv01367
Filed: October 17, 2022
Court: US District Court for the District of Delaware
Presiding Judge: Colm F Connolly
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. § 271 Patent Infringement
Jury Demanded By: None
Docket Report

This docket was last retrieved on December 15, 2022. A more recent docket listing may be available from PACER.

Date Filed Document Text
December 15, 2022 Filing 23 Letter to The Honorable Colm F. Connolly from Andrew C. Mayo regarding proposed order for discovery and stay of other proceedings. (Attachments: #1 Text of Proposed Order)(Mayo, Andrew)
December 9, 2022 Filing 22 Joint STIPULATION TO EXTEND TIME to Submit a Form of Proposed Order to December 15, 2015 - filed by Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc.. (Haynes, Christine)
December 1, 2022 Opinion or Order SO ORDERED, re (21 in 1:22-cv-01367-CFC, 29 in 1:22-cv-01125-CFC, 20 in 1:22-cv-01226-CFC) MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Paul W. Browning, Denise Main, Jennifer H. Roscetti, Erin M. Sommers, Jeanette M. Roorda, and Melanie Magdun, filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Ordered by Judge Colm F. Connolly on 12/1/2022. Associated Cases: 1:22-cv-01125-CFC, 1:22-cv-01226-CFC, 1:22-cv-01367-CFC(kmd)
November 30, 2022 Filing 21 MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Paul W. Browning, Denise Main, Jennifer H. Roscetti, Erin M. Sommers, Jeanette M. Roorda, and Melanie Magdun - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Mayo, Andrew)
November 30, 2022 Opinion or Order SO ORDERED, re (28 in 1:22-cv-01125-CFC) (20 in 1:22-cv-01367-CFC) (19 in 1:22-cv-01226-CFC) MOTION for Pro Hac Vice Appearance of Attorney Brandon M. White, Shannon M. Bloodworth, Emily J. Greb, Maria A. Stubbings, and Jonathan I. Tietz, filed by Viatris Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. Ordered by Judge Colm F. Connolly on 11/30/2022. Associated Cases: 1:22-cv-01125-CFC, 1:22-cv-01226-CFC, 1:22-cv-01367-CFC(kmd)
November 29, 2022 Filing 20 MOTION for Pro Hac Vice Appearance of Attorney Brandon M. White, Shannon M. Bloodworth, Emily J. Greb, Maria A. Stubbings, and Jonathan I. Tietz - filed by Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc.. (Haynes, Christine)
November 29, 2022 Filing 19 NOTICE of Appearance by Jason James Rawnsley on behalf of Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc. (Rawnsley, Jason)
November 23, 2022 Filing 18 REQUEST for Oral Argument by Mylan Pharmaceuticals Inc., Viatris Inc. re #13 MOTION to Dismiss for Failure to State a Claim . (Cottrell, Frederick)
November 23, 2022 Filing 17 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Viatris Inc.. (Cottrell, Frederick)
November 23, 2022 Filing 16 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mylan Inc., Other Affiliate Viatris Inc. for Mylan Pharmaceuticals Inc. filed by Mylan Pharmaceuticals Inc.. (Cottrell, Frederick)
November 22, 2022 Filing 15 REQUEST for Oral Argument by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd. re #13 MOTION to Dismiss for Failure to State a Claim . (Balick, Steven)
November 22, 2022 Filing 14 ANSWERING BRIEF in Opposition re #13 MOTION to Dismiss for Failure to State a Claim filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..Reply Brief due date per Local Rules is 11/29/2022. (Balick, Steven)
November 8, 2022 Filing 13 MOTION to Dismiss for Failure to State a Claim - filed by Mylan Pharmaceuticals Inc., Viatris Inc.. (Attachments: #1 Text of Proposed Order)(Cottrell, Frederick)
November 8, 2022 Filing 12 NOTICE of Appearance by Christine Dealy Haynes on behalf of Mylan Pharmaceuticals Inc., Viatris Inc. (Haynes, Christine)
November 8, 2022 Filing 11 NOTICE of Appearance by Frederick L. Cottrell, III on behalf of Mylan Pharmaceuticals Inc., Viatris Inc. (Cottrell, Frederick)
November 8, 2022 Opinion or Order Filing 10 SO ORDERED, re #9 Stipulation Regarding Mylan Pharmaceutical Inc.'s and Viatris Inc.'s Response to the Complaint, filed by Viatris Inc., Mylan Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 11/8/2022. (kmd)
November 7, 2022 Filing 9 STIPULATION Regarding Mylan Pharmaceutical Inc.'s and Viatris Inc.'s Response to the Complaint by Mylan Pharmaceuticals Inc., Viatris Inc.. (Haynes, Christine)
October 19, 2022 Filing 8 SUMMONS Returned Executed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S.Mylan Pharmaceuticals Inc. served on 10/18/2022, answer due 11/8/2022. (Balick, Steven)
October 19, 2022 Filing 7 SUMMONS Returned Executed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S.Viatris Inc. served on 10/18/2022, answer due 11/8/2022. (Balick, Steven)
October 19, 2022 Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (nms)
October 17, 2022 Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka Holdings Co., Ltd. for Otsuka Pharmaceutical Co., Ltd. filed by Otsuka Pharmaceutical Co., Ltd.. (lam)
October 17, 2022 Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by H. Lundbeck A/S. (lam)
October 17, 2022 Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,400,087. (lam)
October 17, 2022 Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: September 30, 2022. Date of Expiration of Patent: September 24, 2033.Thirty Month Stay Deadline: 8/24/2024. (lam)
October 17, 2022 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lam)
October 17, 2022 Filing 1 COMPLAINT For Patent Infringement against Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc. ( Filing fee $ 402, receipt number ADEDC-3984197.) - filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(lam)
October 17, 2022 No Summons Issued. (lam)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Otsuka Pharmaceutical Co., Ltd.
Represented By: Steven J. Balick
Represented By: Andrew Colin Mayo
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: H. Lundbeck A/S
Represented By: Steven J. Balick
Represented By: Andrew Colin Mayo
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Mylan Laboratories Limited
Represented By: Frederick L. Cottrell, III
Represented By: Christine Dealy Haynes
Represented By: Jason James Rawnsley
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Viatris Inc.
Represented By: Frederick L. Cottrell, III
Represented By: Christine Dealy Haynes
Represented By: Jason James Rawnsley
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Mylan Pharmaceuticals Inc.
Represented By: Jason James Rawnsley
Represented By: Frederick L. Cottrell, III
Represented By: Christine Dealy Haynes
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?